315 related articles for article (PubMed ID: 24869717)
1. Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.
Chen J; Meng H; Xu L; Liu J; Kong D; Chen P; Gong X; Bai J; Zou F; Yang Z; Li C; Eikelboom JW
J Thromb Thrombolysis; 2015 Jan; 39(1):23-34. PubMed ID: 24869717
[TBL] [Abstract][Full Text] [Related]
2. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
Bundhun PK; Qin T; Chen MH
BMC Cardiovasc Disord; 2015 Oct; 15():118. PubMed ID: 26450578
[TBL] [Abstract][Full Text] [Related]
3. Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry.
Song PS; Song YB; Yang JH; Hahn JY; Choi SH; Choi JH; Lee SH; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
Heart Vessels; 2015 Jul; 30(4):458-68. PubMed ID: 24682436
[TBL] [Abstract][Full Text] [Related]
4. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Zuliani Mauro MF; Mangione JA; Costa JR; Costa R; Piva E Mattos LA; Staico R; Feres F; Siqueira D; Sousa A; Abizaid A
J Invasive Cardiol; 2017 Mar; 29(3):76-81. PubMed ID: 28255102
[TBL] [Abstract][Full Text] [Related]
5. Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention.
Zheng XT; Chen KY; Liu T; Xu LX; Che JJ; Rha SW; Li GP
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):29-33. PubMed ID: 26414108
[TBL] [Abstract][Full Text] [Related]
6. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
Trials; 2010 Aug; 11():87. PubMed ID: 20735821
[TBL] [Abstract][Full Text] [Related]
7. Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials.
Zhao S; Zhong Z; Qi G; Shi L; Tian W
Clin Drug Investig; 2019 Jan; 39(1):1-13. PubMed ID: 30251232
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.
Chen Y; Zhang Y; Tang Y; Huang X; Xie Y
Curr Med Res Opin; 2014 Jan; 30(1):37-49. PubMed ID: 24083626
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
Sakurai R; Koo BK; Kaneda H; Bonneau HN; Nagai R
Int J Cardiol; 2013 Sep; 167(5):2250-8. PubMed ID: 22727963
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Kim DK; Seol SH; Kim DI; Cho KI; Kim BH; Park YH; Je HG; Jeong YH; Kim WJ; Lee JY; Lee SW
Cardiology; 2012; 122(3):133-43. PubMed ID: 22832424
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
12. Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials.
Huang F
BMC Pharmacol Toxicol; 2018 Jun; 19(1):31. PubMed ID: 29914573
[TBL] [Abstract][Full Text] [Related]
13. Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel?
Niazi AK; Dinicolantonio JJ; Lavie CJ; O'Keefe JH; Meier P; Bangalore S
Cardiology; 2013; 126(4):233-43. PubMed ID: 24107485
[TBL] [Abstract][Full Text] [Related]
14. Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease.
Youn YJ; Lee JW; Ahn SG; Lee SH; Choi H; Yu CW; Hong YJ; Kwon HM; Hong MK; Jang Y; Yoon J
Am Heart J; 2014 Feb; 167(2):241-248.e1. PubMed ID: 24439986
[TBL] [Abstract][Full Text] [Related]
15. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
Noh Y; Lee J; Shin S; Lim HS; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
PLoS One; 2016; 11(3):e0150475. PubMed ID: 26939062
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.
Tamhane U; Meier P; Chetcuti S; Chen KY; Rha SW; Grossman MP; Gurm H
EuroIntervention; 2009 Aug; 5(3):384-93. PubMed ID: 19736165
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trials.
Ding XL; Xie C; Jiang B; Gao J; Zhang LL; Zhang H; Zhang JJ; Miao LY
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):222-8. PubMed ID: 23263383
[TBL] [Abstract][Full Text] [Related]
20. Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.
Lee HJ; Yu CW; Hwang HK; Choi RK; Park JS; Li H; Ro YM
Coron Artery Dis; 2013 Nov; 24(7):542-8. PubMed ID: 23994880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
